Results 141 to 150 of about 141,466 (220)

Developing Machine Learning‐Based Prognostic Models for Nonmelanoma Skin Cancer Patients With Comorbid Diabetes: A Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Nonmelanoma skin cancer (NMSC) is one of the most common malignancies worldwide, with increasing incidence. Type 2 diabetes mellitus (T2DM) is a prevalent comorbidity that may adversely affect cancer prognosis through shared metabolic and inflammatory pathways.
Junjie Huang   +8 more
wiley   +1 more source

Prevalence and characteristics of gallstone disease in an Iranian population: a study on cadavers [PDF]

open access: yes
BACKGROUND: The prevalence of gallstones is low in Asians. In Iran, many factors influence the prevalence of this disease. The aim of this study was to determine the prevalence of gallbladder stones and their chemical characteristics in a population by ...
شیخ وطن, مهرداد   +3 more
core  

Real‐World Validation of the MAGIC‐D Index in Unresectable Biliary Tract Cancer Treated With Durvalumab Plus Chemotherapy

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
Real‐world Validation of the MAGIC‐D Index. The MAGIC‐D index was validated using real‐world data from patients with unresectable BTC who received durvalumab‐chemotherapy at Tongji Hospital. The risk stratification ability of the MAGIC‐D index for patient survival was improved after incorporating Ki67 and CA 19‐9.
Tianao Zhan   +9 more
wiley   +1 more source

Investigating Risk Factors for Delayed Melanoma Recurrence Beyond 5 Years Post‐Primary Tumor Diagnosis

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Patients undergoing treatment for cutaneous melanoma are generally considered cured after a period of 5 years, since most recurrences manifest within three to 5 years. However, some patients can present with a delayed recurrence of melanoma beyond a 10‐year timeframe.
Kaspar Itin   +18 more
wiley   +1 more source

Upfront Comprehensive Genomic Profiling in Advanced Biliary Tract Cancer: Real‐World Implementation and Clinical Outcomes

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Background Biliary Tract Cancers (BTCs) are difficult‐to‐treat malignancies with limited therapeutic options and dismal prognosis. Upfront comprehensive genomic profiling (CGP) is recommended for advanced BTC to identify actionable alterations, but its real‐world implementation remains underexplored. Methods In 2019, we implemented upfront CGP
Saskia Hussung   +13 more
wiley   +1 more source

Outcomes for Patients With Primary Gastrointestinal Follicular Lymphoma: Results From a Multicenter Analysis

open access: yesCancer Medicine, Volume 15, Issue 11, November 2026.
ABSTRACT Introduction Gastrointestinal (GI) follicular lymphoma (FL) is a rare disease, accounting for less than 5% of GI non‐Hodgkin's lymphomas (NHL). We conducted a multi‐institutional study to clarify baseline features, common practices, and survival outcomes in primary GI FL.
Frederique St‐Pierre   +26 more
wiley   +1 more source

Carcinoma adenoescamoso de la vesícula biliar, una rara variedad histológica

open access: yesRevista Colombiana de Cirugía
El carcinoma adenoescamoso primario de la vesícula biliar es una variante poco conocida e infrecuente de este tipo de neoplasias, cuya etiología y comportamiento siguen constituyendo un enigma. Se trata de una paciente de 45 años de edad con un carcinoma
Katherine Redondo   +5 more
doaj  

Home - About - Disclaimer - Privacy